Justin Bowers
Stock Analyst at Deutsche Bank
(1.88)
# 3,115
Out of 5,182 analysts
41
Total ratings
37.5%
Success rate
4.36%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $370 → $330 | $342.75 | -3.72% | 5 | Mar 25, 2026 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $430.32 | -0.07% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $176.42 | +50.21% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $14.53 | +58.29% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $22.82 | +27.08% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $22.01 | +13.58% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $125.61 | +23.40% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $466.76 | +30.69% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $56.68 | +44.67% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $8.05 | +210.56% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.85 | +341.56% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $121.32 | +147.28% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $174.63 | +57.48% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $309.97 | -19.35% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $185.39 | +56.43% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $16.44 | +179.81% | 5 | May 10, 2021 |
Waters
Mar 25, 2026
Maintains: Hold
Price Target: $370 → $330
Current: $342.75
Upside: -3.72%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $430.32
Upside: -0.07%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $176.42
Upside: +50.21%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $14.53
Upside: +58.29%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $22.82
Upside: +27.08%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $22.01
Upside: +13.58%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $125.61
Upside: +23.40%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $466.76
Upside: +30.69%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $56.68
Upside: +44.67%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $8.05
Upside: +210.56%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.85
Upside: +341.56%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $121.32
Upside: +147.28%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $174.63
Upside: +57.48%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $309.97
Upside: -19.35%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $185.39
Upside: +56.43%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $16.44
Upside: +179.81%